Kobe, Japan

Kaya Tai

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kaya Tai: Innovator in Lung Cancer Detection

Introduction

Kaya Tai is a notable inventor based in Kobe, Japan, recognized for his contributions to the field of medical technology, particularly in lung cancer detection. With a total of two patents to his name, Tai has developed innovative solutions that enhance the accuracy of cancer diagnostics.

Latest Patents

Kaya Tai's latest patents include a determination device, a computer-readable medium, and a marker for obtaining information on lung cancer. The determination device enables a computer to analyze the methylation status of specific genes, such as HOXB4 and ZSCAN31, in DNA samples. This analysis results in valuable information regarding lung cancer in the subject. Additionally, Tai has developed a kit and method for determining the success of unmethylated cytosine conversion treatment, which is crucial for analyzing methylated DNA.

Career Highlights

Throughout his career, Kaya Tai has worked with prominent organizations, including Sysmex Corporation and The University of Tokyo. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in cancer research.

Collaborations

Kaya Tai has collaborated with notable colleagues, including Ayako Sakai and Noriaki Yamamoto. These partnerships have fostered a collaborative environment that promotes innovation and the development of cutting-edge technologies.

Conclusion

Kaya Tai's innovative work in lung cancer detection exemplifies the impact of technology on healthcare. His patents and collaborations highlight his commitment to improving diagnostic methods and ultimately enhancing patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…